Schizophrenia – Epidemiology – Europe

  • The number of diagnosed lifetime prevalent cases of schizophrenia in the European countries under study will increase by 16% from 948 thousand to 1 million in 20 years.
  • Of the countries considered in this analysis, the diagnosed lifetime prevalence of schizophrenia is highest in the Netherlands at 9 per 1,000.
  • The average age of all diagnosed lifetime prevalent cases of schizophrenia in the countries under study is 48.
  • 54% of all diagnosed lifetime prevalent cases of schizophrenia in the countries under study are male.

Table of contents

  • Schizophrenia - Epidemiology - Europe
    • Introduction
      • Key Updates
      • Diagnosed Lifetime Prevalence of Schizophrenia per 1,000 Adults in 2021 and 2041
      • Relative Sizes of the Factors Contributing to the Trend in Diagnosed Lifetime Prevalent Cases of Schizophrenia over the Next 20 Years
      • Number of Additional Diagnosed Lifetime Prevalent Cases of Schizophrenia Across the Countries Under Study Due to Trends in Risk or Survival in 2041
    • Epidemiology Data
    • Methods
      • Lifetime Prevalent Cases
      • Diagnosed Lifetime Prevalent Cases
      • Positive and Negative Symptom Status
      • Comorbid Cognitive Impairment
      • Comorbid Depression
      • Percentage Drug-Treated
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Schizophrenia
        • Studies Excluded from the Analysis of Schizophrenia
      • Risk/Protective Factors
        • Risk/Protective Factors for Schizophrenia
      • Bibliography
        • Abbreviations
        • Glossary

Login to access report